智通财经APP讯,启明医疗-B(02500)发布截至2024年12月31日止年度业绩,该集团期内取得收益人民币4.71亿元。公告称,于报告期内,公司持续聚焦结构性心脏病领域,通过优化研发管线布局,进一步提升研发效率,集中资源推进核心重点管线的临床进展。全球临床研发项目取得多项重要里程碑,展现公司强大的全球临床研发及运营实力,国际化进程不断深化。公司自主研发首款自膨干瓣TAVR产品Venus-...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.